Evidence overview
Vitamin C
Vitamin C is one of the longest-studied dietary supplements, with research spanning the common cold, immune function, iron absorption, wound healing, cardiovascular markers, and antioxidant effects. The picture on its most-popular use - routine cold prevention - is more nuanced than common belief, while several less-asked uses have stronger evidence than the marketing implies.
Most studied for
Coverage pending
PubMed coverage
Coverage pending
Safety profile
In your full report
Mechanism class
Water-soluble essential vitamin that humans cannot synthesize (unlike most mammals). Functions as a cofactor...
Study coverage
Study coverage by goal
PubMed counts for Vitamin C grouped by the goal each study targets.
Evidence overview is temporarily unavailable for Vitamin C.
Evidence
What the evidence covers
The terrain of the published literature, not its conclusions.
Vitamin C is one of the most-researched essential nutrients in modern supplement science, with a literature spanning cold and respiratory infection prevention, non-heme iron-absorption enhancement, immune function, wound healing, cardiovascular markers (blood pressure, endothelial function), and antioxidant effects. The body cannot synthesize vitamin C, so dietary intake is required to prevent classical deficiency (scurvy). The supplemental form is almost always ascorbic acid or its sodium/calcium salts; liposomal preparations are marketed for better absorption but have thinner head-to-head trial data.
The outcome dimensions covered most heavily are the common cold (the most-studied indication, subject of multiple Cochrane reviews), non-heme iron absorption (the established physiological role that drives the AGA recommendation to pair vitamin C with oral iron), respiratory tract infections beyond the classic cold framing, wound healing (especially in post-surgical and pressure-ulcer contexts), and cardiovascular markers. Newer growth areas include high-dose intravenous administration in oncology and critical care, which is methodologically separate from oral supplementation and addresses different clinical questions than the consumer-supplement use case.
Demographically, healthy adults dominate the cold-prevention literature, with substantial pediatric and athletic-population subsamples. The cold-prevention question has been the subject of multiple Cochrane updates, with the literature focused on distinguishing routine supplementation in the general population from supplementation in populations under acute physical stress (athletes, soldiers in cold environments) - a distinction that shapes how the synthesized evidence is interpreted. Most trials do not measure baseline plasma ascorbate, which means pooled analyses cannot cleanly distinguish replete-population effects from deficient-population effects - a recurring methodological limitation that the literature has begun to address.
Safety
Safety summary
Common adverse events, drug interactions, and special populations.
Vitamin C is generally well-tolerated at typical supplemental doses. The most-common adverse effects at higher doses are gastrointestinal: nausea, diarrhea, and abdominal cramping, more frequent at single doses above 1,000 mg. The IOM tolerable upper limit for adults is 2,000 mg/day. Long-term very-high-dose use has been associated with an increased risk of oxalate kidney stones in susceptible individuals. Drug interactions are limited but practical: vitamin C enhances non-heme iron absorption (sometimes desired, sometimes not depending on iron status), can reduce serum copper at very high intakes, and has a contested interaction with some chemotherapy agents that warrants clinician discussion in oncology contexts. People with hemochromatosis, glucose-6-phosphate dehydrogenase deficiency, or recurrent kidney stones should consult a clinician before high-dose supplementation.
This summary is informational and not medical advice. Consult a clinician before starting or changing any supplement, especially if you take prescription medications.
Foundations
Foundation of the evidence base
A few studies the field anchors on. Not the full picture, just the starting points.
The definitive Cochrane synthesis on vitamin C for the common cold, the supplement's most-asked consumer use. Synthesizes decades of trial data on both routine and high-dose vitamin C and remains the field's anchor for this question.
View on PubMedAmerican Gastroenterological Association practice guideline that includes a specific recommendation for vitamin C alongside oral iron, anchoring the well-established absorption-enhancement role and giving vitamin C clear practice-guideline status outside its cold-related uses.
View on PubMedUpdated synthesis extending the vitamin C evidence beyond the classic common-cold framing into respiratory tract infections more broadly, the second-most-cited body of vitamin C clinical research.
View on PubMed
Limitations
What this page doesn't answer
Where the public summary stops and the personalized report begins.
This page summarizes the vitamin C literature at a general level. It does not address whether your habitual dietary intake already meets your needs (most adults exceed the IOM RDA through diet alone), what dose to use for your specific goal, whether timing or form matters for your case, or how vitamin C interacts with the medications and other supplements you take. Whether you actually benefit from supplementation depends heavily on baseline intake, current health context, and which specific outcome you're targeting - all questions the personalized report can address with your context.
Personalized to you
Get a personalized Vitamin C report
Your free first report adds the things this page doesn't: per-goal evidence breakdown, demographic-specific findings, full citation list, and a safety section tailored to your profile.
Free first report. No credit card. Cancel anytime.
Get notified when new evidence appears
We'll email you when the literature on Vitamin C materially updates. No account required.